menu close
www.billiontoone.com
Billiontoone-Logo

BillionToOne IPO

NASDAQ: BLLN

Company Profile:

BillionToOne completed their IPO on November 6, 2025. Now that BillionToOne is a public company, Nasdaq Private Market does not actively track its performance. The data below is for reference before the company’s IPO.

BillionToOne is a next-generation molecular diagnostics company focused on enhancing disease detection and quantification through its proprietary Quantitative Counting Technology (QCT), which enables precise analysis of DNA molecules at the single base-pair level for applications in prenatal screening and oncology.

Sign up for SecondMarket® to invest in or sell private companies like BillionToOne before their IPO.
Buy + Sell
  • Headquarters: Menlo Park, CA
  • Year Founded: 2016
  • Sector: Health Care
Leverage Your Equity to Help Achieve More.

BillionToOne Funding Pre-IPO

Gain insights into BillionToOne funding history prior to their IPO, including the funding round, time period, and amount raised.

Sign Up to Unlock the Data
Financing Round Date Amount Price per share* Valuation*
Series C Sep 19, 2022 30.00M
Price
Valuation
Series C Mar 30, 2022 125.00M
Price
Valuation
Series B Jun 14, 2021 16.02M
Price
Valuation
Series B Jun 14, 2021 55.00M
Price
Valuation
Series A Mar 13, 2019 15.00M
Price
Valuation
Series A Mar 13, 2019 902.43K
Price
Valuation
Series A Mar 13, 2019 50.00K
Price
Valuation
Series A Mar 13, 2019 910.00K
Price
Valuation
Series A Mar 13, 2019 100.00K
Price
Valuation
Series A Mar 13, 2019 537.57K
Price
Valuation

*Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market Tape D®

Leverage Your Equity to Help Achieve More.

BillionToOne Management Team - Prior to IPO

  • Chief Medical Officer

    Gary Palmer

  • Chief Product Officer

    Shan Riku

  • Co-Founder, CEO

    Oguzhan Atay

  • CFO

    Ross Taylor

  • Co-Founder, CTO

    David Tsao

BillionToOne Major Investors - Prior to IPO

  • Norwest Venture Partners

  • Baillie Gifford

  • Libertus Capital

  • Y Combinator

  • Pacific 8 Ventures

  • Time BioVentures

  • Fifty Years

  • HOF Capital

  • Four Rivers Group

  • Adams Street Partners

  • Hummingbird Ventures

  • Civilization Ventures

  • 500 Startups

  • NeoTribe Ventures

Learn More About BillionToOne Stock

Buy BillionToOne Stock
01

BillionToOne became publicly traded following its IPO on November 6, 2025, its shares now trade on public stock exchanges under the ticker symbol NASDAQ: BLLN. Before the IPO, BillionToOne stock was privately held and available only through private market transactions.

If you’re an accredited investor looking to purchase pre-IPO shares in a private company, Nasdaq Private Market can help you get started. Learn more about investing in the private market or sign up for free to explore available opportunities. Learn more about how private company shares trade prior to an IPO on our investors page.

Sell BillionToOne Stock
02

Following its IPO on November 6, 2025, BillionToOne shares trade on public stock exchanges, allowing shareholders to sell stock through a traditional brokerage.

If you currently hold shares in a private company, Nasdaq Private Market may be able to help you explore your sell private company stock. Our platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To understand how employees sell shares before a company goes public, visit the Employee Shareholders page.

BillionToOne Stock Price
03

Following the IPO, BillionToOne stock prices can now be viewed publicly on major exchanges. Investors and interested parties can find the current stock price by searching BillionToOne’s ticker symbol on financial platforms such as Nasdaq.com or through their preferred brokerage platform.

BillionToOne Stock Ticker Symbol
04

Following its IPO on November 6, 2025, BillionToOne stock now trades on public markets under the ticker symbol NASDAQ: BLLN. You can view real-time stock information through widely used financial data platforms.

Criteria to Sell BillionToOne Stock
05

Following the BillionToOne IPO, public shares can be sold through any brokerage.

Nasdaq Private Market works with employees, ex-employees, and other private company shareholders of pre-IPO companies to sell their shares. The Nasdaq Private Market platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To learn more about how to sell private company stock, visit the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

Criteria to Buy or Invest in BillionToOne Stock
06

Following BillionToOne’s initial public offering on November 6, 2025, its shares are now listed on a public exchange and available for purchase through a brokerage account. Investors interested in buying BillionToOne stock can do so through their preferred broker, just as they would with any other publicly traded security.

Nasdaq Private Market continues to work with investors seeking exposure to private company opportunities prior to IPO. Through structured transactions and curated offerings, investors can participate in private market activity before companies enter the public markets.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

BillionToOne Stock Settlement
07

Since BillionToOne is now publicly traded, public-market share transfers and settlement occur automatically through a brokerage or exchange.

Nasdaq Private Market supports transfer and settlement for privately held company equity. In order to buy or sell private company stock, share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patented Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

BillionToOne IPO
08

BillionToOne completed its IPO on November 6, 2025, and is now publicly available through major financial sources.

Sign up for SecondMarket® to invest in or sell private companies like BillionToOne before their IPO.
Buy + Sell

*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.

Other Companies

Curology-Logo

Curology

Offers personalized prescription skin care medications delivered directly to you.

Devoted

Provides Medicare Advantage plans to improve older Americans' well-being with comprehensive and family-oriented care.

Virta Health-Logo

Virta Health

Online specialty medical clinic focused on reversing type 2 diabetes.

Cerebral

Telemedicine mental health startup, providing evidence-based therapeutic techniques and medication management.

Color-Logo

Color Genomics

Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

Roman Health Ventures-Logo

Ro

Healthcare technology for a patient-centric healthcare system.

Nutcracker Therapeutics-Logo

Nutcracker Therapeutics

Uses high-technology engineering and advanced biosynthesis to advance mRNA therapeutics through strategic partnerships with clinical institutions and pharmaceutical/biotech companies.

Attovia Therapeutics-Logo

Attovia

Pipeline of bio-therapeutics with an initial focus on immune-mediated diseases.

Scribe Therapeutics-Logo

Scribe

Focused on the development of CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.

Source: Nasdaq Private Market Tape D®